EUCTR2009-016463-10-DE进行中（未招募）不适用
Antidepressive response to add-on occupational therapy in patients with major depression: A randomized controlled multicentre trial
WL University Hospital Bochum0 个研究点开始时间: 2010年1月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •· male and female inpatients, 18 to 65 years of age
- •· patients must have a diagnosis of moderate or severe major depression without psychotic or catatonic features as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV: 296.22, 296.23, 296.32, 296.33), and confirmed by the Structured Clinical Interview for DSM (SCID-I)
- •· Hamilton Depression Rating Scale (HamD-17) score = 18
- •· female patients must test negative for pregnancy and, if of childbearing potential, must be using a highly effective method of birth control (Pearl Index < 1%) before entry and throughout the study. Effective methods of birth control include oral hormonal contraceptives, contraceptive injections, contraceptive patch and male partner sterilization.
- •· patients in whom a minimum in-patient hospitalisation stay of at least 7 weeks (when enrolled in the study) is acceptable, in the clinical judgement of the investigator
- •· patients must be considered reliable, have a level of understanding sufficient to perform all tests and examinations required by the protocol
- •· patients must be able to understand the nature of the study and have given their own informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •· patients in whom treatment with mirtazapine is relatively or absolutely clinically contraindicated
- •· patients who have received an experimental drug or used an experimental medical device for any indication within 30 days prior to Visit 1
- •· patients who have a history of inadequate response to an adequate treatment with mirtazapine, in the opinion of the investigator
- •· patients who require concomitant treatment with any other medication with primary central nervous system activity, other than benzodiazepines
- •· patients at risk of suicide (e.g. history of any suicide attempts, any current suicidal intent including plan)
- •· DSM-IV diagnosis of dementia, schizophrenia spectrum disorder, bipolar affective disorder, cluster A or cluster B personality disorder, substance use disorder (abuse and dependence), and some forms of anxiety disorders (acute panic disorder, acute agoraphobia, acute social phobia, and acute general anxiety disorder), eating disorders (anorexia and bulimia nervosa)
- •· history of convulsion or seizure disorder
- •· severe physical disabilities
- •· female patients who are pregnant, nursing, or who intend to become pregnant within 30 days of completing the study
- •· aminotransferase levels > 2 times upper limit of normal (ULN) at Visit 1
- •· thyroid-stimulating hormone (TSH) > 10% above the ULN at Visit 1
- •· clinically significant ECG abnormalities at Visit 1
- •· patients with acute, serious, or unstable medical conditions
- •· employees of the investigator or study center, with direct involvement in the proposed study or other studies under the direction of that investigator or study center, as well as family members of the employees or the investigator
研究者
相似试验
已完成
不适用
Antidepressant efficacy and mechanism of add-on cognitive activation to repetitive transcranial magnetic stimulation in depressioA randomized sham-controlled studyJPRN-UMIN000008421Taipei Veterans General Hospital36
尚未招募
不适用
Clinical evaluation of the antidepressant effect of the use of probiotics in bipolar disorderRBR-5dhhhddniversidade de São Paulo
招募中
2 期
Augmenting treatment for Major Depression with a Positivity-AAT-TrainingF32.0F32.1F32.2F33.0F33.1F33.2F34.1Mild depressive episodeModerate depressive episodeSevere depressive episode without psychotic symptomsRecurrent depressive disorder, current episode mildRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsDysthymiaDRKS00020463Clinical PsychologyBehavioural Science InstituteRadboud University Nijmegen200
尚未招募
4 期
A clinical trial to study the effect of a combination therapy (oral ketamine and escitalopram) and escitalopram alone in elderly patient with depression, when given early in the course of treatment.CTRI/2023/04/051777King George Medical University
尚未招募
不适用
Behavioural Activation for depressive symptoms in young people with emerging or early psychosis: a pilot study protocolDepressionACTRN12622000756729Charles Darwin University,60